The membrane mesenchymal stem cell derived conditioned medium exerts neuroprotection against focal cerebral ischemia by targeting apoptosis
- PMID: 30121327
- DOI: 10.1016/j.jchemneu.2018.08.004
The membrane mesenchymal stem cell derived conditioned medium exerts neuroprotection against focal cerebral ischemia by targeting apoptosis
Abstract
Objective: The mesenchymal stem cells derived from human amniotic membrane have the ability to secrete and release some factors that can promote the repair of damaged tissues. This secretome contains proteins and factors that reduce apoptosis and increase angiogenesis in the ischemia/reperfusion models. The present study was conducted to determine whether this secretome provides protection against transient focal cerebral ischemia.
Materials and methods: A rat model of focal cerebral ischemia was established through middle cerebral artery occlusion (MCAO) for 60 min and 24 h reperfusion. The amniotic mesenchymal stem cells-conditioned medium (AMSC-CM) at the dose of 0.5 μl was injected intracerebroventriculary (ICV) 30 min after reperfusion. Infarct volume, brain edema, neurobehavioral functions, and blood brain barrier (BBB) integrity were assessed 24 h after reperfusion. Neuronal loss and expression of caspase-3, Bax and Bcl-2 in motor cortex were evaluated by nissl staining and immunohistochemistry assay respectively.
Results: ICV administration of AMSC-CM markedly reduced infarct volume, brain edema and the evans blue penetration rate compared with MCAO group (P < 0.05). Additionally, post-treatment with AMSC-CM significantly reduced neuronal loss, neurological motor disorders and expression of caspase-3, Bax and Bcl-2 in motor cortex compared with MCAO group (P < 0.05).
Conclusion: The results of this study indicate that treatment with AMSC-CM improves the pathological effects in the acute phase of cerebral ischemia. These findings establish a substantial foundation for stroke therapy and future research.
Keywords: Apoptosis; Blood brain barrier integrity; Conditioned medium; Focal cerebral ischemia; Mesenchymal stem cells.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
Neuroprotective Effects of Conditioned Medium of Mesenchymal Stem Cells (MSC-CM) as a Therapy for Ischemic Stroke Recovery: A Systematic Review.Neurochem Res. 2023 May;48(5):1280-1292. doi: 10.1007/s11064-022-03848-x. Epub 2022 Dec 30. Neurochem Res. 2023. PMID: 36581731 Review.
-
Conditioned medium obtained from mesenchymal stem cells attenuates focal cerebral ischemia reperfusion injury through activation of ERK1/ERK2-BDNF signaling pathway.J Chem Neuroanat. 2019 Apr;97:87-98. doi: 10.1016/j.jchemneu.2019.02.003. Epub 2019 Feb 18. J Chem Neuroanat. 2019. PMID: 30790626
-
An-Gong-Niu-Huang Wan protects against cerebral ischemia induced apoptosis in rats: up-regulation of Bcl-2 and down-regulation of Bax and caspase-3.J Ethnopharmacol. 2014 May 28;154(1):156-62. doi: 10.1016/j.jep.2014.03.057. Epub 2014 Mar 29. J Ethnopharmacol. 2014. PMID: 24690773
-
Conditioned medium obtained from human amniotic mesenchymal stem cells attenuates focal cerebral ischemia/reperfusion injury in rats by targeting mTOR pathway.J Chem Neuroanat. 2019 Dec;102:101707. doi: 10.1016/j.jchemneu.2019.101707. Epub 2019 Oct 28. J Chem Neuroanat. 2019. PMID: 31672459
-
Neuroprotection by mesenchymal stem cell (MSC) administration is enhanced by local cooling infusion (LCI) in ischemia.Brain Res. 2019 Dec 1;1724:146406. doi: 10.1016/j.brainres.2019.146406. Epub 2019 Aug 24. Brain Res. 2019. PMID: 31454517 Review.
Cited by
-
Conditioned medium obtained from human amniotic membrane-derived mesenchymal stem cell attenuates heart failure injury in rats.Iran J Basic Med Sci. 2019 Nov;22(11):1253-1258. doi: 10.22038/ijbms.2019.36617.8722. Iran J Basic Med Sci. 2019. PMID: 32128088 Free PMC article.
-
Intravenous Administration of Human Amniotic Mesenchymal Stem Cells in the Subacute Phase of Cerebral Infarction in a Mouse Model Ameliorates Neurological Disturbance by Suppressing Blood Brain Barrier Disruption and Apoptosis via Immunomodulation.Cell Transplant. 2021 Jan-Dec;30:9636897211024183. doi: 10.1177/09636897211024183. Cell Transplant. 2021. PMID: 34144647 Free PMC article.
-
Neuroprotective Effects of Conditioned Medium of Mesenchymal Stem Cells (MSC-CM) as a Therapy for Ischemic Stroke Recovery: A Systematic Review.Neurochem Res. 2023 May;48(5):1280-1292. doi: 10.1007/s11064-022-03848-x. Epub 2022 Dec 30. Neurochem Res. 2023. PMID: 36581731 Review.
-
Paracrine Effects of Mesenchymal Stem Cells in Ischemic Stroke: Opportunities and Challenges.Mol Neurobiol. 2022 Oct;59(10):6281-6306. doi: 10.1007/s12035-022-02967-4. Epub 2022 Aug 3. Mol Neurobiol. 2022. PMID: 35922728 Review.
-
Comparison of the effects of intramyocardial and intravenous injections of human mesenchymal stem cells on cardiac regeneration after heart failure.Iran J Basic Med Sci. 2020 Jul;23(7):879-885. doi: 10.22038/ijbms.2020.40886.9660. Iran J Basic Med Sci. 2020. PMID: 32774809 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials